Musculoskeletal System Disorders Market Growth, Demand Overview and Industry Forecast to 2023


Posted February 7, 2020 by gadewarshri

Musculoskeletal System Disorders Market, Musculoskeletal System Disorders Market Size, Musculoskeletal System Disorders Market Share, Musculoskeletal System Disorders Market Overview
 
Market Highlights:
Musculoskeletal system disorders affect movement or musculoskeletal systems such as muscles, tendons, and ligaments. These disorders are also known as repetitive motion injuries. Musculoskeletal system disorders can arise by making the same motion repeatedly or lifting heavy objects. They affect different parts of the body, mainly the upper and lower back and neck.
According to MRFR analysis, the global musculoskeletal system disorders market is expected to register a CAGR of ~5.30% during the forecast period of 2019 to 2025 and was valued at USD 3837.7 million in 2018.
The growth of global Musculoskeletal System Disorders Market Growth is driven by various factors such as an increasing global geriatric population, rising prevalence, and improper posture, and poor fitness levels. However, the high costs of surgery are expected to curb the growth of the global musculoskeletal system disorders market.
Key Players:
• AB Science
• AbGenomics International
• Alder BioPharmaceuticals
• Amgen Inc
• Lexicon Pharmaceuticals
• LG Chem
• OrthoTrophix
• Tarsa Therapeutics
• PhytoHealth Corporatio
• Eisai Co
• Astellas Pharma Inc
• AstraZeneca
• Baxter
• GlaxoSmithKline PLC
Segmentation:
• The global musculoskeletal system disorders market has been segmented based on type, treatment, and end user.
• The market, based on type, has been divided into rheumatoid arthritis, osteoarthritis, osteoporosis, psoriatic arthritis, ankylosing spondylitis, fibromyalgia, and others.
• The global musculoskeletal system disorders market has been segmented, on the basis of treatment, into corticosteroids, biologics, physical therapy, extracorporeal shock wave therapy, protein therapy, synthetic bone graft, composite grafts, demineralized bone matrix, and others.
• The end user segments of the market are hospitals and clinics, ambulatory surgical centers, and others. The hospitals and clinics segment is expected to hold the largest share of the market as these centers are the primary locations for patients receiving treatment and surgery.
Regional Analysis:
The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the increasing prevalence of musculoskeletal system disorders and rising per capita healthcare expenditure. The musculoskeletal system disorders market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European musculoskeletal system disorders market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The musculoskeletal system disorders market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing patient pool of musculoskeletal system disorders and rising awareness about the treatment methods, the market in Asia-Pacific is expected to be the fastest-growing. The musculoskeletal system disorders market in the Middle East & Africa has been divided into the Middle East and Africa.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By gadewar shri
Phone 08329909276
Business Address Office No. 528, Amanora Chambers
Pune - 411028
Country India
Categories Biotech , Business , Free
Tags musculoskeletal system disorders market , musculoskeletal system disorders market share , musculoskeletal system disorders market size
Last Updated February 7, 2020